ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 164970 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 164970; 2) Community: the network communities that were significantly associated with the response to NSC 164970; 3) Molecule: the relationships between components within communities and NSC 164970; 4) MDR: the compounds that were significantly associated with the NSC 164970.

NSC Compound Enrichment Correlation
NSC 119754 Berbinium, 7,8,13,13a-tetradehydro-2,3:9,10-bis(methylenedioxy)-, chloride (8CI) 0.00862782236704185 0.34750782
NSC 135077 BERSALDEGENIN 1,3,5-ORTHOACETATE 0.00862782236704185 0.23050743
NSC 163664 Arsinothious acid, dimethyl-, 2,4-pyrimidinediyl ester (9CI) 0.00862782236704185 0.322136
NSC 657299 Null 0.00862782236704185 0.19613119
NSC 670283 2,2'-Spirobi[2H-benz[f]indene]-5,5'-dione, 1,1',3,3',5,5',6,6',7,7',8,8'-dodecahydro- 0.00862782236704185 0.41492618
NSC 679108 Phenol, 4,4'-(5,5'-biisoxazole-3,3'-diyl)bis- 0.00862782236704185 0.40900643
NSC 681642 Camptothecin Derivative 0.00862782236704185 0.27068949
NSC 682823 Propanimidoyl chloride, N-[[[(3,4-dichlorophenyl)amino] carbonyl]oxy]-2-methyl- 0.00862782236704185 0.33722778
NSC 749 Azaguanine 0.00862782236704185 0.30365088
NSC 619860 Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine 0.00896740831404549 0.41249527
Total:96  Current:30    [First] [Prev] [Next] [Last]